EASD 2014 in Vienna
On 17 September 2014 Novo Nordisk will host an investor and analyst event in connection with the European Association for the Study of Diabetes (EASD) annual meeting.
The event will be hosted by Chief Financial Officer Jesper Brandgaard and Chief Science Officer Mads Krogsgaard Thomsen.
Presentations and a Q&A session will be transmitted via webcast from 17:30–19:30 CET, 17 September.
Link to the conference call webcast will is available here
The presentation will also be available in the Download Centre.